Results 241 to 250 of about 726,640 (329)
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons +17 more
wiley +1 more source
Invasive Pneumococcal Disease Presenting as Austrian Syndrome in a Patient With HIV Infection: A Case Report. [PDF]
Jani S, Khaja M.
europepmc +1 more source
Abstract Objective To identify long‐term predictors of seizure outcome after anterior temporal lobectomy (ATL) in a large, homogeneous cohort of patients with drug‐resistant temporal lobe epilepsy (TLE) and MRI‐defined unilateral hippocampal sclerosis (HS), all operated on by a single neurosurgeon with extended follow‐up.
Thiago Pereira Rodrigues +9 more
wiley +1 more source
Pregnancy and neonatal outcomes of HIV infection in pregnant women in Iran: a systematic review and meta-analysis. [PDF]
Azizi H +5 more
europepmc +1 more source
Medicare Part D and Hospital Admissions due to Antimicrobial Resistance
ABSTRACT Antimicrobial resistance (AMR) has been increasing rapidly in the United States despite government efforts to contain its spread. Both under‐utilization and overuse of prescribed antimicrobials contribute to rising resistance. The introduction of Medicare Part D in 2006 expanded prescription drug coverage for the elderly, including coverage ...
Ricardo B. Ang III
wiley +1 more source
Extracellular Vesicles Favor Early Peripheral Immunosenescence Through Modulation of the Senescence-Associated Secretory Phenotype in HIV Infection. [PDF]
Castro RC +11 more
europepmc +1 more source

